Skip to content

RLG Med

Active Private limited companyfounded 2024active for 2 yearsTijl Uilenspiegeldreef 6, 1070 AnderlechtKBO/BCE: BE 1004.191.114

Lifetime

2 annual accounts with figures on one time axis
peak of €100,632 in 2025
€100,632▲ 8.1%
peak of €78,109 in 2025
€78,109▲ 7.9%
peak of €150,139 in 2025
€150,139▲ 104%
€13,254▼ 55.6%
Board2 names since 2024
2 directors and 1 other
Documentsfilings and deeds
28-07-20263 days before the deadline
2025micro format
Dividend €1,666Equity from €73,696 to €150,139Debts from €29,850 to €13,254Cash from €51,783 to €32,930

Key points

from the 2025 annual accounts

Equity

€150,139 ▲ 104%
€73,7002024€150,0002025

Equity rose in 2025 from €73,696 to €150,139.

Liquidity

11.89 was 3.24 in 2024

Short-term debts fell from €29,850 to €13,254.

Position in the sector

91.9%

Higher solvency than 86% of companies in human health. The sector median is 63.0%, over 21,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,327 companies had the same profile as RLG Med has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,327 companies, not a prediction for RLG Med. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
  • founderdeed of 05-01-2024
  • founderdeed of 05-01-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1004191114
Incorporation Founding capital of €3,000, 100 shares · Founded by and · (director) and (director) appointed · published on 05-01-2024 · Gazette deed
All 7 events

Comparable companies

same main activity, similar in size and age
Company
RLG Med Anderlecht €163,393 €100,632 91.9% -
Fit Medical Schaerbeek €152,538 €108,075 99.0% -
DR. CLAESSENS LUCAS Maaseik €164,964 €100,429 79.6% -
DR LEEN WEYENBERG Lint €154,657 €101,651 98.7% -
Dokter Sien Van Herck Mechelen €160,284 €103,026 81.2% -
DR. BUEKENS Knokke-Heist €158,416 €98,475 78.3% -
Dr. Anass El Malahi Boom €166,786 €99,226 98.6% -

These companies have the same main activity as RLG Med: general medical practice (NACE 86210). They are comparable in size and age: total assets between €153,000 and €167,000, founded between 2023 and 2024.

Official details

Source: KBO
Status
Active since 03-01-2024Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.354.553.4521070 Anderlecht, since 03-01-2024
Financial year end
31 December
Peppol
Reachable since 06-01-2026
Company details

Annual accounts 2025

≈ €180,000estimated
€163,393▲ 57.8%
Filing
Filed on 28-07-2026, 3 days before the end of the filing period
Financials

Insights on RLG Med

RLG Med has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €150,139 and a net result of €78,109.

Its solvency ranks better than 87% of 21,385 sector peers (NACE 86) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about RLG Med

What is the company number of RLG Med?
The company number of RLG Med is 1004.191.114. The VAT number is the same number with BE in front: BE 1004.191.114.
Where is RLG Med based?
The registered office is at Tijl Uilenspiegeldreef 6, 1070 Anderlecht.Company details
What does RLG Med do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of RLG Med?
RLG Med is a private limited company (BV).
When was RLG Med founded?
RLG Med was founded on 03-01-2024.
Is RLG Med still active?
Yes, RLG Med is an active enterprise in the KBO register.
What is the turnover of RLG Med?
The turnover in financial year 2025 is about €180,000. This figure is estimated from the gross margin of €100,632 and 30 comparable companies (NACE 86210). It probably lies between €150,000 and €230,000.Financials
Is RLG Med profitable?
In financial year 2025, RLG Med made a profit of €78,109.
Where can I find the annual accounts of RLG Med?
RLG Med filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of RLG Med due?
RLG Med must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.